Senate committee substitute makes the following changes to the 1st edition.
Clarifies that the Director of the Division of Public Health of the Department of Health and Human services (DHHS) and the Director of the Division of Medical Assistance, DHHS, are among the state health officials and health care provider licensing boards that are to develop statewide opioid prescribing guidelines for adoption by the health care provider occupational licensing boards. Also clarifies that other state and federal prescribing guidelines should be used as models to define and develop North Carolina's statewide opioid prescribing guidelines.
Clarifies that the acronym, CSRS, represents Controlled Substances Reporting System. Directs DHHS to improve the CSRS contract, and specifies modifications to be made to the contract to do so, including directing DHHS to execute a memorandum of understanding with the National Association of Boards of Pharmacy to participate in PMP (Prescription Monitoring Program) InterConnect (was, directed that the contract be modified to include interstate connectivity with the states of South Carolina, Tennessee, and Virginia).
Directs DHHS to apply for grant funding from the National Association of Boards of Pharmacy to establish the initial connection to PMP InterConnect (was, directed DHHS to use $40,035 of existing grant funding from the Harold Rogers Prescription Drug Monitoring Program for fiscal year 2014-15 to create interstate connectivity for the drug monitoring program). Additionally directs DHHS to request $40,035 for establishing the connection and $30,000 for two years of ongoing service, maintenance, and support for PMP InterConnect.
Deletes the requirement that DHHS seek grant funding to offset connectivity costs.
Amends the appropriations from the General Fund to DHHS as follows: (1) appropriates $15,000 for fiscal year 2014-15, non-recurring, (was, $10,000 for fiscal year 2014-15 in recurring funds) to cover the cost of annual services fees for the interstate connection for the drug monitoring program and (2) appropriates $40,035 for fiscal year 2014-15 to establish the initial interface for PMP InterConnect as required in this act.Requires that the amounts in each of these appropriations be adjusted or eliminated if DHHS successfully obtains grant awards or is able to identify other allowable receipts for these purposes. Provides that if other receipts are used for either of these purposes, the non-recurring appropriation must revert to the General Fund.
Adds a representative from the North Carolina Board of Pharmacy as a member of the Prescription Drug Abuse Advisory Committee, established in this act.
STRENGTHEN CONTROLLED SUBSTANCES MONITORING.
Printer-friendly: Click to view
View NCGA Bill Details | 2013-2014 Session |
AN ACT TO STRENGTHEN THE MONITORING OF CONTROLLED SUBSTANCES.Intro. by Hartsell, Clark.
Bill History:
-
Wed, 14 May 2014 Senate: Filed
-
Thu, 15 May 2014 Senate: Passed 1st Reading
-
Thu, 15 May 2014 Senate: Ref To Com On Health Care
-
Wed, 11 Jun 2014 Senate: Reptd Fav Com Substitute
-
Wed, 11 Jun 2014 Senate: Com Substitute Adopted
-
Wed, 11 Jun 2014 Senate: Re-ref Com On Appropriations/Base Budget
Bill Summaries:
-
Bill S 749 (2013-2014)Summary date: Jun 11 2014 - View Summary
-
Bill S 749 (2013-2014)Summary date: May 15 2014 - View Summary
Identical to H 1037, filed 5/14/14.
Requires the following entities to develop opioid prescribing guidelines for adoption by the health care provider licensing boards: (1) State Health Director; (2) Director of Medical Assistance; (3) Director of the Division of Mental Health, Developmental Disabilities, and Substance Abuse Services; (4) directors of medical, dental, and mental health services within the Department of Public Safety; (5) NC Board of Dental Examiners; (6) NC Board of Nursing; (7) NC Board of Podiatry Examiners; and (8) NC Medical Board. Sets forth requirements for developing the guidelines. Requires that the guidelines be completed by December 31, 2014 and that the licensing boards adopt the guidelines by July 1, 2015.
Requires the following to require continuing education on the abuse of controlled substances as a condition of license renewal for providers prescribing controlled substances: (1) NC Board of Dental Examiners, (2) NC Board of Nursing, (3) NC Board of Podiatry Examiners, and (4) NC Medical Board. Requires that at least one hour be a course specifially addressing prescribing practices.
Amends GS 90-113.74 to expand upon the permitted uses of prescription information to include informing medical records and clinical care. Allows the release of data in the controlled substances reporting system to the federal Drug Enforcement Adminstration's Office of Diversion Control and the NC Health Information Exchange. Requires the Department of Health and Human Services (DHHS) to adopt policies and procedures documenting and supporting the additional fuctionality and expanded access for the NC Controlled Substances Reporting System (System) and for the added entities, and amend its contract with the vendor operating the System to support the added functionality and expanded access.
Requires DHHS to modify the contract for the System to improve performance, establish user access controls, establish data security protocols, and ensure availabiilty of data for advanced analytics. Specifies modifications to be made. The contract modifications must be complete by December 31, 2014, and DHHS must report by November 15, 2014, to the Joint Legislative Program Evaluation Oversight Committee and the Joint Legislative Oversight Committee on Health and Human Services on progress in modifying the contract. Requires DHHS to use $40,035 of existing grant funding from the Harold Rogers Prescription Drug Monitoring Program for 2014-15 to create a connection to the RxCheck Hub to create connectivity for the drug monitoring program. Makes additional appropriations from the General Fund in the amounts of $5,100, $15,000, and $10,000 for activities related to the System and drug monitoring program. Requires DHHS to seek grant funding to offset the cost of providing interstate connectivity for the System.
Requires the System to expand its monitoring capacty by establishing data use agreements with the Prescription Behavior Surveillance System. Requires the System to establish data use agreement with the Center of Excellence at Brandeis University by January 1, 2015.
Requires the Division of Mental Health, Developmental Disabilities, and Substance Abuse Services to report every two years, beginning September 1, 2015, on its participaton with the Prescription Behavior Surveillance System to the Joint Legislative Oversight Committee on Health and Human Services and the Joint Legislative Oversight Committee on Justice and Public Safety.
Requires the Division of Medical Assistance to take six specified steps to improve the effectiveness and efficiency of the Medicaid lock-in program, including establishing written procedures for the operation of the program, and increasing program capacity. Requries a report to the Joint Legislative Program Evaluation Oversight Committee by September 30, 2014, on its progress.
Creates the Prescription Drug Abuse Advisory Committee (Committee), and requires it to implement a statewide strategic plan to combat the problem of prescription drug abuse. Requires that the Committee include representatives from specified entities as well as others designated by the Secretary of Health and Human Services. After developing the plan, the Committee will be the state's steering commitee to monitor achievement and receive regular progess reports. Specifies steps that must be completed in developing the plan. Requires the plan to include three to five strategic goals that are outcome-oriented and measurable. The goals must be connected with objectives supported by four specified system mechanisms. Requires DHHS, in consultation with the Committee, to implement a performance management system that connects the goals and objectives identified in the plan to operations of the Controlled Substances Reporting System and Medicaid lock-in program, law enforcement activites, and oversight of prescribers and dispensers. Requries DHHS to submit an annual report, beginning December 1, 2015, on the peformance of the system for monitoring prescription drug abuse to the Joint Legislative Oversight Committee on Health and Human Services and the Joint Legislative Oversight Committe on Justice and Public Safety.
Committee substitute to the 1st edition changed the long title. Original long title was A BILL TO BE ENTITLED AN ACT TO STRENGTHEN THE MONITORING OF CONTROLLED SUBSTANCES, AS RECOMMENDED BY THE JOINT LEGISLATIVE PROGRAM EVALUATION OVERSIGHT COMMITTEE.